Europe - EPA:AKE - FR0010313833 - Common Stock
We assign a fundamental rating of 5 out of 10 to AKE. AKE was compared to 66 industry peers in the Chemicals industry. AKE has an average financial health and profitability rating. AKE is valued quite cheap, but it does not seem to be growing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 2.9% | ||
| ROIC | 3.44% | 
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.35% | ||
| PM (TTM) | 2.22% | ||
| GM | 19.02% | 
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 16.7 | ||
| Altman-Z | 1.86 | 
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.73 | ||
| Quick Ratio | 1.92 | 
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.87 | ||
| Fwd PE | 7.17 | 
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.82 | ||
| EV/EBITDA | 4.44 | 
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.96% | 
EPA:AKE (11/3/2025, 7:00:00 PM)
50.2
-1.3 (-2.52%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.96% | 
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.87 | ||
| Fwd PE | 7.17 | ||
| P/S | 0.4 | ||
| P/FCF | 16.82 | ||
| P/OCF | 3.76 | ||
| P/B | 0.53 | ||
| P/tB | 1.78 | ||
| EV/EBITDA | 4.44 | 
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 2.9% | ||
| ROCE | 4.88% | ||
| ROIC | 3.44% | ||
| ROICexc | 3.86% | ||
| ROICexgc | 7.22% | ||
| OM | 6.35% | ||
| PM (TTM) | 2.22% | ||
| GM | 19.02% | ||
| FCFM | 2.4% | 
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 16.7 | ||
| Debt/EBITDA | 2.56 | ||
| Cap/Depr | 95.75% | ||
| Cap/Sales | 8.36% | ||
| Interest Coverage | 17.14 | ||
| Cash Conversion | 71.35% | ||
| Profit Quality | 108.1% | ||
| Current Ratio | 2.73 | ||
| Quick Ratio | 1.92 | ||
| Altman-Z | 1.86 | 
ChartMill assigns a fundamental rating of 5 / 10 to AKE.PA.
ChartMill assigns a valuation rating of 7 / 10 to ARKEMA (AKE.PA). This can be considered as Undervalued.
ARKEMA (AKE.PA) has a profitability rating of 4 / 10.
The Price/Earnings (PE) ratio for ARKEMA (AKE.PA) is 7.87 and the Price/Book (PB) ratio is 0.53.
The financial health rating of ARKEMA (AKE.PA) is 5 / 10.